Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sargent

Showing results (361-370 of 433) with videos related to

Pageof 44
Sort By:
Cancer|June 15, 2007
Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX) : intergroup trial N9741 in first-line treatment of metastatic colorectal cancerAmanda C Ashley, Daniel J Sargent, Steven R Alberts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2011
A noncanonical Flt3ITD/NF-κB signaling pathway represses DAPK1 in acute myeloid leukemiaRajasubramaniam Shanmugam, Padmaja Gade, Annique Wilson-Weekes, et al.
The Oncologist|February 12, 2017
Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) TrialsXiaofei Wang, Xiaoyi Wang, Lydia Hodgson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 23, 2018
Physical Activity and Outcomes in Patients with Stage III Colon Cancer: A Correlative Analysis of Phase III Trial NCCTG N0147 (Alliance)Amanda I Phipps, Qian Shi, Tyler J Zemla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Thymidylate synthase expression in colon carcinomas with microsatellite instabilityFrank A Sinicrope, Rafaela L Rego, Kevin C Halling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2010
Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741Howard L McLeod, Daniel J Sargent, Sharon Marsh, et al.
Journal of Geriatric Oncology|July 30, 2016
Validity of Adjuvant! Online in older patients with stage III colon cancer based on 2967 patients from the ACCENT databaseDemetris Papamichael, Lindsay A Renfro, Christiana Matthaiou, et al.
International Journal of Cancer|April 11, 2016
Alcohol consumption and colon cancer prognosis among participants in north central cancer treatment group phase III trial N0147Amanda I Phipps, Qian Shi, Paul J Limburg, et al.
The Lancet. Oncology|December 17, 2016
Estimation of tumour regression and growth rates during treatment in patients with advanced prostate cancer: a retrospective analysisJulia Wilkerson, Kald Abdallah, Charles Hugh-Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancerDaniel J Sargent, Claus Henning Köhne, Hanna Kelly Sanoff, et al.
Pageof 44

Showing results (361-370 of 433) with videos related to

Sort By:
Pageof 44
Cancer|June 15, 2007
Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX) : intergroup trial N9741 in first-line treatment of metastatic colorectal cancerAmanda C Ashley, Daniel J Sargent, Steven R Alberts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2011
A noncanonical Flt3ITD/NF-κB signaling pathway represses DAPK1 in acute myeloid leukemiaRajasubramaniam Shanmugam, Padmaja Gade, Annique Wilson-Weekes, et al.
The Oncologist|February 12, 2017
Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) TrialsXiaofei Wang, Xiaoyi Wang, Lydia Hodgson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 23, 2018
Physical Activity and Outcomes in Patients with Stage III Colon Cancer: A Correlative Analysis of Phase III Trial NCCTG N0147 (Alliance)Amanda I Phipps, Qian Shi, Tyler J Zemla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Thymidylate synthase expression in colon carcinomas with microsatellite instabilityFrank A Sinicrope, Rafaela L Rego, Kevin C Halling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2010
Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741Howard L McLeod, Daniel J Sargent, Sharon Marsh, et al.
Journal of Geriatric Oncology|July 30, 2016
Validity of Adjuvant! Online in older patients with stage III colon cancer based on 2967 patients from the ACCENT databaseDemetris Papamichael, Lindsay A Renfro, Christiana Matthaiou, et al.
International Journal of Cancer|April 11, 2016
Alcohol consumption and colon cancer prognosis among participants in north central cancer treatment group phase III trial N0147Amanda I Phipps, Qian Shi, Paul J Limburg, et al.
The Lancet. Oncology|December 17, 2016
Estimation of tumour regression and growth rates during treatment in patients with advanced prostate cancer: a retrospective analysisJulia Wilkerson, Kald Abdallah, Charles Hugh-Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancerDaniel J Sargent, Claus Henning Köhne, Hanna Kelly Sanoff, et al.
Pageof 44